Short- and Long-Term Outcomes of an Adventure Therapy Programme on Borderline Personality Disorder: A Pragmatic Controlled Clinical Trial.

Adventure Therapy borderline personality disorder clinical trial longitudinal study treatment

Journal

Brain sciences
ISSN: 2076-3425
Titre abrégé: Brain Sci
Pays: Switzerland
ID NLM: 101598646

Informations de publication

Date de publication:
29 Feb 2024
Historique:
received: 21 01 2024
revised: 19 02 2024
accepted: 26 02 2024
medline: 28 3 2024
pubmed: 28 3 2024
entrez: 28 3 2024
Statut: epublish

Résumé

Adventure Therapy (AT) is a therapeutic intervention utilizing the natural environment and adventure activities as tools for psychotherapeutic interventions. It has been demonstrated to be appropriate for the intervention of patients with borderline personality disorder (BPD). This study aims to evaluate the response to AT treatment compared with the response to treatment as usual (TAU), based on cognitive behavioural therapy, in the short and long term, assessing clinical, psychosocial, and functional outcomes; quality of life; and physical health levels. This study extends the sample of and is a follow-up to a pilot study published in 2021, with a sample of 30 patients in the AT group and 10 in the control group. It does not allow us to affirm that AT provides better outcomes than TAU, as the positive effects observed immediately after therapy seem to be attenuated in the long term. Therefore, the effectiveness of long-term psychotherapy did not show differences between AT and TAU therapies in the treatment of BPD patients. However, the effects of intangibles observed during therapy by professionals and patients were not reflected in the measurements collected. Therefore, we believe it is necessary to increase the programme duration, complement treatment with a specific physical health programme, assess results with more specific instruments, and/or move towards a qualitative methodology to measure perceived changes in clinical improvement. New studies are needed to evaluate the results of the proposed changes.

Identifiants

pubmed: 38539624
pii: brainsci14030236
doi: 10.3390/brainsci14030236
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Diputació de Lleida
ID : 12.800 €
Organisme : Ultra Trail Terres de Lleida
ID : 1.236,93 €
Organisme : Club Tennis Lleida
ID : 800 €
Organisme : Col·legi d'Aparelladors, Arquitectes tècnics i Enginyers d'Edificació of Lleida
ID : 1.000 €
Organisme : Diputació de Lleida and Projectes d'Impuls a la Recerca en Salut 2022 (PIRS 22/03)
ID : 50.000 €

Auteurs

Alba Gabarda-Blasco (A)

Psychiatry Service, University Hospital Santa Maria, Avinguda Rovira Roure 44, 25198 Lleida, Spain.

Aina Elias (A)

Psychiatry Service, University Hospital Santa Maria, Avinguda Rovira Roure 44, 25198 Lleida, Spain.

Mariona Mendo-Cullell (M)

Psychiatry Service, University Hospital Santa Maria, Avinguda Rovira Roure 44, 25198 Lleida, Spain.

Laura Arenas-Pijoan (L)

Psychiatry Service, University Hospital Santa Maria, Avinguda Rovira Roure 44, 25198 Lleida, Spain.

Carles Forné (C)

Heorfy Consulting, 25007 Lleida, Spain.
Department of Basic Medical Sciences, University of Lleida, 25006 Lleida, Spain.

David Fernandez-Oñate (D)

Psychiatry Service, University Hospital Santa Maria, Avinguda Rovira Roure 44, 25198 Lleida, Spain.

Laura Bossa (L)

Psychiatry Service, University Hospital Santa Maria, Avinguda Rovira Roure 44, 25198 Lleida, Spain.
Biomedical Research Institute of Lleida Dr. Pifarré Foundation (IRB Lleida), 25198 Lleida, Spain.

Aurora Torrent (A)

Psychiatry Service, University Hospital Santa Maria, Avinguda Rovira Roure 44, 25198 Lleida, Spain.
Biomedical Research Institute of Lleida Dr. Pifarré Foundation (IRB Lleida), 25198 Lleida, Spain.

Xavier Gallart-Palau (X)

Biomedical Research Institute of Lleida Dr. Pifarré Foundation (IRB Lleida), 25198 Lleida, Spain.
Neuroscience Area, +Pec Proteomics Research Group (+PPRG), University Hospital Arnau de Vilanova (HUAV), 25198 Lleida, Spain.
Psychology Department, University of Lleida (UdL), 25006 Lleida, Spain.
Faculty of Health Sciences, Valencian International University, 46002 Valencia, Spain.

Iolanda Batalla (I)

Psychiatry Service, University Hospital Santa Maria, Avinguda Rovira Roure 44, 25198 Lleida, Spain.
Biomedical Research Institute of Lleida Dr. Pifarré Foundation (IRB Lleida), 25198 Lleida, Spain.
Medicine Department, Faculty of Medicine, University of Lleida (UdL), 25006 Lleida, Spain.

Classifications MeSH